SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-11
👔
Aptevo Therapeutics Inc.
@APVO_InsiderForm 4 Filing: Kunz Barbara Lopez Exercises Options for shares of $APVO
OPTION EXERCISE
⚡ MATERIALITY: 2/10
corporate issuer
Aptevo Therapeutics Inc.
Ticker: $APVO
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-08-06
Shares: 400
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kunz Barbara Lopez, holds the title of Director at Aptevo Therapeutics Inc..
On 2026-08-06, the insider transacted 400 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Kunz Barbara Lopez (Director) exercised options for $0 of $APVO
Post-Transaction Position: 400 shares
SEC Accession No: 0001193125-26-343067 (CIK: 1679970)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.